Utility of Film Array Meningoencephalitis Panel in Children With Acute Encephalitis Syndrome: A Single Centre

Dona Teresa Thomas1, P A Kunju Mohammed2, Greeshma Baby2

  • 1Department of Pediatric Neurology, Kerala Institute of Medical Sciences, Trivandrum, Kerala, India. Correspondence to: Dr. Dona Teresa Thomas, Senior Resident, Department of Pediatric Neurology, Kerala Institute of Medical Sciences, Trivandrum, Kerala, India. donsteresa34@gmail.com.

Indian Pediatrics
|May 13, 2024
PubMed

Insights

The Film Array Meningoencephalitis (FAME) panel rapidly identifies pathogens in children with acute encephalitis syndrome (AES), aiding in reduced empirical antibiotic and antiviral therapy.

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Microbiology
  • Neuroscience

Background:

  • Acute Encephalitis Syndrome (AES) poses a significant diagnostic challenge in pediatric populations.
  • Timely and accurate etiological diagnosis is crucial for effective management and improved patient outcomes.

Purpose of the Study:

  • To evaluate the clinical utility of the Film Array Meningoencephalitis (FAME) panel in diagnosing pediatric AES.
  • To assess the impact of FAME panel results on empirical antimicrobial and antiviral treatment strategies.

Main Methods:

  • A retrospective audit of pediatric patients diagnosed with AES was conducted.
  • Cerebrospinal fluid (CSF) samples were analyzed using the FAME panel within 48 hours of admission.
  • Patient electronic medical records were reviewed for clinical data, investigations, and outcomes.

Main Results:

  • The FAME panel identified the etiology in 31.4% of tested CSF samples.
  • Viral pathogens were the most common (e.g., Enterovirus, HHV-6), followed by bacterial and fungal agents.
  • Establishment of a specific etiology allowed for de-escalation of empirical antibiotic and antiviral therapies in a significant proportion of children.

Conclusions:

  • The FAME panel is an effective tool for rapid etiological diagnosis in pediatric AES.
  • Utilizing the FAME panel can lead to a reduction in the duration of empirical antibiotic and antiviral treatments, optimizing patient care.
Abstract

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...